tiprankstipranks
Advertisement
Advertisement
X4 Pharmaceuticals receives positive CHMP opinion for mavorixafor
PremiumThe FlyX4 Pharmaceuticals receives positive CHMP opinion for mavorixafor
2M ago
One new option listing and  option delistings on January 20th
Premium
The Fly
One new option listing and option delistings on January 20th
4M ago
X4 Pharmaceuticals price target raised to $10 from $7.50 at Stifel
Premium
The Fly
X4 Pharmaceuticals price target raised to $10 from $7.50 at Stifel
5M ago
X4 Pharmaceuticals 45.87M share Spot Secondary priced at $2.85
PremiumThe FlyX4 Pharmaceuticals 45.87M share Spot Secondary priced at $2.85
6M ago
X4 Pharmaceuticals announces common stock offering, no amount given
Premium
The Fly
X4 Pharmaceuticals announces common stock offering, no amount given
7M ago
Altimmune appoints Christophe Arbet-Engels as CMO
Premium
The Fly
Altimmune appoints Christophe Arbet-Engels as CMO
7M ago
X4 Pharmaceuticals Announces Board Resignations and Appointments
PremiumCompany AnnouncementsX4 Pharmaceuticals Announces Board Resignations and Appointments
8M ago
3 Penny Stocks to Watch Now, 8/14/25
Premium
Market News
3 Penny Stocks to Watch Now, 8/14/25
9M ago
X4 Pharmaceuticals Closes $85M Private Placement Deal
Premium
Company Announcements
X4 Pharmaceuticals Closes $85M Private Placement Deal
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100